Owusu Boahen

Kintampo, BA, Ghana

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Effectiveness of the RTS,S/AS01E malaria vaccine in a real-world setting over 1 year of follow-up after the three-dose primary schedule: an interim analysis of a phase 4 study in Ghana, Kenya, and Malawi.

Effectiveness of the RTS,S/AS01E malaria vaccine in a real-world setting over 1 year of follow-up after the three-dose primary schedule: an interim analysis of a phase 4 study in Ghana, Kenya, and Malawi.

Journal: The Lancet. Global health

Published: February 07, 2025

Safety of RTS,S/AS01E malaria vaccine up to 1 year after the third dose in Ghana, Kenya, and Malawi (EPI-MAL-003): a phase 4 cohort event monitoring study.

Safety of RTS,S/AS01E malaria vaccine up to 1 year after the third dose in Ghana, Kenya, and Malawi (EPI-MAL-003): a phase 4 cohort event monitoring study.

Journal: The Lancet. Global health

Published: August 27, 2024

Incidence rates of malaria, meningitis, and mortality in children younger than 5 years: a prospective cohort study in Ghana and Kenya before the roll-out of the RTS,S/AS01E malaria vaccine from 2016 to 2022.

Incidence rates of malaria, meningitis, and mortality in children younger than 5 years: a prospective cohort study in Ghana and Kenya before the roll-out of the RTS,S/AS01E malaria vaccine from 2016 to 2022.

Journal: The Lancet. Global health

Published: January 31, 2024

Assessing the safety, impact and effectiveness of RTS,S/AS01E malaria vaccine following its introduction in three sub-Saharan African countries: methodological approaches and study set-up.

Assessing the safety, impact and effectiveness of RTS,S/AS01E malaria vaccine following its introduction in three sub-Saharan African countries: methodological approaches and study set-up.

Journal: Malaria journal

Published: June 04, 2021

Potential effect modification of RTS,S/AS01 malaria vaccine efficacy by household socio-economic status.

Potential effect modification of RTS,S/AS01 malaria vaccine efficacy by household socio-economic status.

Journal: BMC public health

Published: October 01, 2020

Estimating Annual Fluctuations in Malaria Transmission Intensity and in the Use of Malaria Control Interventions in Five Sub-Saharan African Countries.

Estimating Annual Fluctuations in Malaria Transmission Intensity and in the Use of Malaria Control Interventions in Five Sub-Saharan African Countries.

Journal: The American journal of tropical medicine and hygiene

Published: September 22, 2020

Immunogenicity and safety of the RTS,S/AS01 malaria vaccine co-administered with measles, rubella and yellow fever vaccines in Ghanaian children: A phase IIIb, multi-center, non-inferiority, randomized, open, controlled trial.

Immunogenicity and safety of the RTS,S/AS01 malaria vaccine co-administered with measles, rubella and yellow fever vaccines in Ghanaian children: A phase IIIb, multi-center, non-inferiority, randomized, open, controlled trial.

Journal: Vaccine

Published: November 27, 2019

Community perception and beliefs about blood draw for clinical research in Ghana.

Community perception and beliefs about blood draw for clinical research in Ghana.

Journal: Transactions of the Royal Society of Tropical Medicine and Hygiene

Published: February 22, 2013

A phase 3 trial of RTS,S/AS01 malaria vaccine in African infants.

A phase 3 trial of RTS,S/AS01 malaria vaccine in African infants.

Journal: The New England journal of medicine

Published: November 10, 2012

First results of phase 3 trial of RTS,S/AS01 malaria vaccine in African children.

First results of phase 3 trial of RTS,S/AS01 malaria vaccine in African children.

Journal: The New England journal of medicine

Published: October 20, 2011

Showing 1-10 of 10

Last Updated: 09/26/2026